Clinical Trials Browser

Phase 1/2 × OTHER × icotinib × Clear all

NCT01534585 2018-04-17

Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma

Phase 1/2 Completed

Nasopharyngeal Carcinoma